2-HPβCD

2-hydroxypropyl-beta-cyclodextrin · ZyVersa Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 2-HPβCD, covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: P2a Open Label Study to Evaluate 2-HPβCD in Subjects With Diabetic Kidney Disease [Phase 2]